Assembly Concurrent Resolution 139 declares March as Sleep Apnea Awareness Month in California and formally recognizes obstructive sleep apnea (OSA) as a significant and underdiagnosed public health issue. The resolution recites clinical consequences of untreated OSA, notes evidence-based treatments, and emphasizes disparities in diagnosis and treatment among Latino, Black, Asian American, and Pacific Islander communities, as well as low-income, rural, and underserved populations.
The measure is ceremonial: it makes a public statement of concern and affirms advancing health equity in prevention, diagnosis, and treatment but does not appropriate funds, create new state programs, or impose regulatory requirements. Agencies, providers, employers, and advocacy groups are left with a symbolic lever to justify outreach, screening drives, and partnership requests rather than any statutory mandate or resource commitment.
At a Glance
What It Does
The resolution formally proclaims March as Sleep Apnea Awareness Month and records findings about OSA’s health risks, available treatments (including CPAP and oral appliance therapy), workforce safety implications, and racial and socioeconomic disparities. It is a concurrent resolution adopted by the Assembly for concurrence by the Senate; it creates no binding legal duties, funding, or regulatory changes.
Who It Affects
Direct legal effect: none. Practical effect: public health departments, sleep medicine clinics, dentists who provide oral appliance therapy, employers and occupational-safety units, insurers, and community health and advocacy organizations that run outreach and screening programs.
Why It Matters
Though symbolic, the resolution codifies a short list of clinical facts and an equity framing that organizations can cite when seeking grants, launching campaigns, or negotiating with insurers and employers. It also signals legislative interest in sleep health and could shape stakeholder priorities even without new money or mandates.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
ACR 139 is a short, declarative document. It begins with a series of 'whereas' clauses that summarize clinical descriptions of obstructive sleep apnea, list comorbid conditions tied to untreated OSA, and cite estimates about the scale of undiagnosed disease nationally.
The text explicitly names evidence-based treatment options — continuous positive airway pressure (CPAP), oral appliance therapy, weight management, and surgery — and calls out custom-fitted mandibular advancement devices and newer FDA-cleared oral therapies as legitimate options. The resolution also frames OSA as a workplace and public-safety risk because of daytime sleepiness and cognitive impairment.
The core operative language contains a handful of short 'resolved' clauses. The first proclaims March as Sleep Apnea Awareness Month in California.
Subsequent resolved clauses recognize OSA as an underdiagnosed public health problem and affirm that addressing disparities in awareness, screening, and treatment is an important health-equity objective. The final clause is procedural: it directs the Chief Clerk of the Assembly to transmit copies of the resolution for distribution.Because this is a concurrent resolution, it carries symbolic weight rather than legal force.
The text does not authorize spending, create new reporting requirements, direct state agencies to adopt rules, or change liability or coverage mandates. The practical uses of the resolution are therefore political and programmatic: public health departments and community organizations can reference it to justify awareness campaigns; sleep clinics and dental practices can use it to support outreach and education; and employers or insurers might cite it when developing internal programs, though they face no statutory obligation under the resolution itself.The resolution’s explicit inclusion of oral appliance therapy and FDA-cleared devices is notable for clinicians and payers: it signals a legislative recognition of non-CPAP options and could be used by dental professional groups to press for broader insurance coverage or inclusion in clinical screening protocols.
At the same time, the document highlights disparities by race, geography, and income without attaching funding or specified interventions, which shapes the political frame but leaves implementation to agencies and private actors.
The Five Things You Need to Know
The resolution cites a U.S. estimate that 75–80 million adults are affected by OSA and states that up to 90% of cases may be undiagnosed.
The text explicitly lists comorbid conditions associated with untreated OSA: hypertension, heart disease, stroke, type 2 diabetes, obesity, depression, and increased all-cause mortality.
The bill names evidence-based therapies by type: continuous positive airway pressure (CPAP), oral appliance therapy (including mandibular advancement devices and newer FDA-cleared devices), weight management, and surgical options.
The resolution singles out Latino, Black, Asian American, and Pacific Islander communities, plus low-income, rural, and underserved populations, as disproportionately affected and more likely to be undiagnosed or untreated.
The only procedural instruction is to have the Chief Clerk of the Assembly transmit copies of the resolution for distribution — the measure does not appropriate funds or direct agencies to act.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Summarizes clinical facts, prevalence estimates, and disparities
The preamble collects the bill’s factual background: a clinical definition of obstructive sleep apnea, national prevalence estimates, the high proportion of undiagnosed cases, a list of adverse health outcomes, and recognition of specific treatment modalities. Practically, these clauses establish the evidentiary record the Assembly wants on file; they are the language stakeholders will cite when arguing for funding, coverage, or programmatic change despite the resolution’s nonbinding nature.
Proclaims March as Sleep Apnea Awareness Month
This is the operative ceremonial proclamation. Proclamations are tools for public messaging: they create a named time-period that government agencies, nonprofits, and private organizations can use to coordinate awareness campaigns, events, and education. Legally, it does not change statutes, budgets, or regulatory obligations.
Recognizes OSA as underdiagnosed and notes safety concerns and treatments
These clauses formally record the legislature’s view that OSA presents individual health risks and workforce/public-safety concerns, and list treatments the Assembly recognizes as evidence-based. For clinicians and payers, the explicit naming of CPAP and oral appliance therapies provides a legislative signal about acceptable standard-of-care options, which advocates may leverage in discussions about coverage policies even though the resolution itself does not alter insurer obligations.
Affirms advancing health equity in prevention, diagnosis, and treatment
This clause focuses on disparities—calling for attention to Latino, Black, Asian American, Pacific Islander, low-income, rural, and underserved communities. The practical implication is agenda-setting: public-health agencies and community groups can point to the resolution when prioritizing outreach or applying for grants, but the clause does not specify targets, metrics, or funding to reduce those disparities.
Administrative transmission
The resolution instructs the Chief Clerk of the Assembly to transmit copies of the resolution to the author for distribution. This is a routine procedural step that facilitates dissemination to stakeholders; it underscores the measure’s informational—not regulatory—purpose.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients in underserved communities: The resolution elevates awareness and frames disparities affecting Latino, Black, Asian American, Pacific Islander, low-income, and rural populations, which community organizations can cite when seeking funding or organizing screening and education.
- Sleep medicine clinics and diagnostic centers: Increased public awareness campaigns may drive demand for screening and testing, creating more referral flow for sleep studies and specialty care.
- Dental practices providing oral appliance therapy: The bill’s explicit recognition of oral appliance options and FDA-cleared devices gives dental professionals public-policy language to support reimbursement discussions and professional outreach.
- Public health departments and community-health NGOs: The proclamation provides a labeled month that agencies can use to structure outreach, partner with employers, and apply for grants tied to health equity initiatives.
- Workplace health and safety programs: Employers and occupational-safety units gain a legislative talking point to justify screening pilots and fatigue-management initiatives without needing external mandates.
Who Bears the Cost
- Insurers and payers (potentially): Greater awareness can increase demand for diagnostic testing and treatment; while the resolution imposes no legal obligation, insurers may face pressure (from advocates and providers) to expand coverage for testing and oral appliance therapies.
- Clinics and sleep labs: A surge in screening referrals without additional funding could strain capacity, causing longer wait times and requiring investment in staff and equipment.
- State and local public-health agencies: Even without a funding mandate, agencies may be expected by constituents to act on the resolution’s equity goals, creating unfunded workload and prioritization pressures.
- Employers with safety-sensitive operations: Employers might feel compelled to institute screening or monitoring programs to address fatigue risks, incurring programmatic and administrative costs despite no statutory requirement.
- Small or rural providers: Increased demand concentrated in underserved areas may outpace local provider capacity, producing compliance and logistical burdens for small clinics with limited resources.
Key Issues
The Core Tension
The central dilemma is symbolic recognition versus practical effect: the resolution raises expectations about addressing an underdiagnosed, inequitable health problem but contains no funding, mandates, or metrics—so it can spotlight issues and mobilize stakeholders, yet also risk producing demand and expectations the system is not resourced to meet.
ACR 139 is explicitly symbolic. It compiles epidemiological estimates and clinical statements into legislative language but does not create enforceable requirements, appropriations, or reporting duties.
That means the resolution’s real-world impact depends entirely on downstream actions by agencies, funders, insurers, employers, and community groups. The absence of implementation detail—no funding streams, no targets, and no agency directives—creates a gap between legislative recognition and measurable change.
Another tension arises from the resolution’s encouragement of awareness and screening while simultaneously naming specific treatments (notably oral appliance therapy and FDA-cleared devices). Highlighting treatment options can empower clinicians and patients, but it also raises coverage and access questions that the bill does not address: increased demand without commensurate coverage or provider capacity risks amplifying disparities.
Finally, the resolution relies on national prevalence estimates rather than California-specific data and provides no metrics for measuring progress, leaving stakeholders without clear benchmarks for assessing whether awareness month activities actually reduce underdiagnosis or improve outcomes.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.